News

Telix to Add FAP-Targeting Candidates to Theranostic Pipeline

View more

Dec 06, 2024

ABK Biomedical Announces FDA IDE Stage 2 Approval for Route90, a Prospective, Multi-Center, Pivotal Study of Eye90 microspheres® in unresectable Hepatocellular Cancer

View more

Dec 05, 2024

Novartis Drops Up to $745M to Move Deeper Into Competitive Radiopharma Space

View more

Dec 02, 2024

PET links chronic stress to aggressive endometrial cancer

View more

Dec 02, 2024

New PET tracer shows promise in patients with kidney cancer

View more

Nov 28, 2024

FAPI-PET/CT superior to FDG-PET/CT in assessing liver cancer

View more

Nov 28, 2024